These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 10091096)

  • 41. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastric acidity in patients with follicular gastritis is significantly reduced, but can be normalized after eradication for Helicobacter pylori.
    Shimatani T; Inoue M; Iwamoto K; Hyogo H; Yokozaki M; Saeki T; Tazuma S; Horikawa Y; Harada N
    Helicobacter; 2005 Jun; 10(3):256-65. PubMed ID: 15904484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis.
    Lahner E; Vaira D; Figura N; Pilozzi E; Pasquali A; Severi C; Perna F; Delle Fave G; Annibale B
    Helicobacter; 2004 Oct; 9(5):436-42. PubMed ID: 15361083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
    Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
    Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
    J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients.
    Labenz J; Tillenburg B; Peitz U; Börsch G; Idström JP; Verdú E; Stolte M; Blum AL
    Am J Gastroenterol; 1997 Apr; 92(4):576-81. PubMed ID: 9128302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
    Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis.
    Sudraba A; Daugule I; Rudzite D; Funka K; Tolmanis I; Engstrand L; Janciauskas D; Jonaitis L; Kiudelis G; Kupcinskas L; Ivanauskas A; Leja M
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):349-54. PubMed ID: 22187698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.
    Kang JM; Kim N; Shin CM; Lee HS; Lee DH; Jung HC; Song IS
    Helicobacter; 2012 Apr; 17(2):86-95. PubMed ID: 22404438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
    Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Martín de Argila C
    Med Clin (Barc); 1995 Nov; 105(15):561-5. PubMed ID: 7500674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of Helicobacter pylori infection and the effects of its eradication on gastric emptying in non-ulcerative dyspepsia.
    Murakami K; Fujioka T; Shiota K; Ito A; Fujiyama K; Kodama R; Kawasaki Y; Kubota T; Nasu M
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S93-7. PubMed ID: 8574747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of Helicobacter pylori serology after successful eradication.
    Cutler AF; Prasad VM
    Am J Gastroenterol; 1996 Jan; 91(1):85-8. PubMed ID: 8561150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
    Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.